Delivery of more drug to the lung may appear to be a desirable goal in the treatment of
asthma and chronic obstructive pulmonary disease, since only 10 to 15% of a drug dose …

Asthma is a chronic inflammatory disease characterized by symptoms of cough, dyspnea,
chest tightness, and wheeze. Inhaled corticosteroids (ICS) have been recommended as …

Background The efficacy of inhaled corticosteroids in the treatment of chronic obstructive
pulmonary disease (COPD) remains controversial because of a lack of placebo-controlled …

Study objectives To compare the lung deposition of radiolabeled hydrofluoroalkane-134a
beclomethasone dipropionate (HFA-BDP) with chlorofluorocarbon fluticasone propionate …

Three hundred forty-nine patients with asthma previously treated with medium doses of
inhaled corticosteroids during a 2-wk, single-blind, run-in period were randomized to …

The aim of the present study was to evaluate the prevalence of adrenal suppression and
growth retardation in children using moderate doses of budesonide or fluticasone …

Introduction The commercially available inhaled corticosteroids (ICS) for asthma treatment
are beclomethasone dipropionate (BDP), budesonide (BUD), flunisolide (FLU), fluticasone …

Background Beclomethasone dipropionate (BDP) and budesonide (BUD) are commonly
prescribed inhaled corticosteroids for the treatment of asthma. Fluticasone propionate (FP) is …

Several classes of medications are available for the treatment of asthma, and often they
must be taken concurrently to achieve asthma control. Based on the understanding of …

The aim of this study was to examine the dose-response relationship of inhaled budesonide
in adolescents and adults with asthma. A meta-analysis was carried out on placebo …